The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.

UK pharma major GSK has gained US regulatory approval for a new prefilled syringe presentation of its shingles vaccine, ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The syringe removes the need to reconstitute separate vials prior to administration, which simplifies the vaccine administration process for healthcare professionals, GSK said Thursday. The existing ...

This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people aged 50 ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

China's Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK's shingles vaccine in China, the UK drugmaker said on Thursday, lower than previously ...

GlaxoSmithKline agent Hz/su (aka GSK 1437173A), a Herpes zoster (shingles) vaccine candidate, met its primary endpoint in a Phase-III trial, the firm said, and is shaping up to be a potential ...

GSK GSK0.28%increase; green up pointing triangle expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the pharma ...

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.